30 May 2016

Bango

(BGO)

Company Details

Address:
5 Westbrook Centre , Cambridge CB4 1YG
Telephone:
01223 472 777
Fax:
01223 472 778
Email:
Ray@bango.com
Website:
www.bango.com

Commentary

Mobile web payments and analytics company

Executives

Non-Exec Chairman:
David Sear (0.0% holding)
Chief Executive:
Ray Anderson (10.3% holding)
CFO:
Rachel Elias-Jones (0.0% holding)
Chief Mktg Officer:
Anil Malhotra (6.2% holding)

Main Shareholders

Liontrust Investment Partners: 17.2%

Herald Investment Management: 14.4%

Odey Asset Management: 10.9%

Inflection Point Investments: 4.9%

Schroders: 4.5%

Advisers

Nominated Adviser:
Cenkos Securities
Nominated Broker:
Cenkos Securities
Solicitors:
Taylor Wessing
Auditors:
Grant Thornton
Registrar:
Computershare Investor Services

Accounts Information

Entry on AIM:
30/6/2005
Issue Price:
134.0p
Interim Results:
Sep
Final Results:
Mar
Year End:
Dec
Accounts Due:
Mar
Int div payment:
n/a
Fin div payment:
n/a
Int net div per share:
nil
Fin net div per share:
nil

Financial History

  2015 2014
Turnover: £3.19m £5.09m
Pre-tax profit: £ (5.03m) £ (5.41m)
EPS: (9.05) p (10.96) p

Associated Articles

Bango 17/09/13

Bango teams with Mozilla 07/08/13

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

The role of a nominated adviser

Dr Azhic Basirov, Head of Capital Markets at Smith & Williamson Corporate Finance explains what to look for in a nominated adviser, along with the nomad’s role, fees and the key questions you should ask. Read this feature on the role of a nominated adviser.

What Investment magazine: save 45% on the shop price

Be the first to receive our independent analysis and research, designed to help you generate more wealth for you and your family over the long term. Subscribe and save.

Popular News

Latest News

Motif Bio and the ticking timebomb 23/05/16

The recently published O'Neill report on antimicrobial resistance shows it to be a ticking timebomb. Resistance to antibiotics raises the prospect of 10 million deaths a year by 2050. This is a big opportunity for AIM listed Motif Bio (AIM: MTFB).      

Make mine a double! 19/05/16

Fevertree Drinks (AIM: FEVR) has been one of the most spectacular new issues on AIM in recent years, rising 412 per cent from the float price in late 2014. Today’s trading update served to emphasise why the shares are doing so well and drove them up another 15 per cent.

Fox Marble might be worth the wait  16/05/16

Fox Marble (AIM: FOX) has raised £2 million through a placing at 10p. The funds will be mainly used to complete its long-delayed marble processing factory in Kosovo. Fox has an exciting story but unfortunately is lagging way behind its original roadmap to profitability.

Business as usual at XL Media  12/05/16

XL Media (AIM: XLM) has announced the result of its strategic review. I hope no one was holding their breath, because the conclusion is to carry on as usual! The good news is that trading is said to have ‘maintained its excellent start to 2016’.

A Quantum of solace 11/05/16

Quantum Pharma (AIM: QP.) committed the cardinal sin of overpromising and under-delivering during its first year on AIM. New products took longer to come through the regulatory process than expected, which caused downgrades and a share price collapse from a high of 172p last June to the current 58p. However results for the financial year which ended in January suggest the company is getting to grips with the problems in its Niche Pharmaceuticals division.

Elecosoft constructs a strategy for growth  09/05/16

Elecosoft (AIM: ELCO) is a specialist software company serving architects and builders. It used to be a much larger business but sold out of its building materials businesses four years ago to focus on its software arm. The challenge now is to generate some revenue growth and move off a sales plateau which has been in place since then.

More News